ALFA Finder| Value | ₹0.23 Cr |
|---|
BSE filing, NSE: BALPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Bal Pharma Ltd: key numbers
- Share price
- ₹88.10
- Market cap
- ₹140.3 Cr
- Revenue (annual)
- ₹311.7 Cr
- Net profit (annual)
- ₹6.28 Cr
- P/E (TTM)
- 17.7×Sector 43.8×
- Promoter holding
- 50.86%+0.00% QoQ
- FII holding
- 0.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bal Pharma Ltd
All →Bal Pharma Other Announcement
Bal Pharma filed a Reg 32 statement confirming no deviation in its ₹2.10 Cr preferential warrant proceeds, with nothing utilised by September 30, 2026. The amount remains fully unutilised.
- Value
- ₹2.10 Cr
Bal Pharma Q2 FY27 Results: Net Profit ₹1.4 Cr, Up 100.0% YoY
Bal Pharma Ltd reported revenue from operations of ₹89.9 Cr (+21.5% YoY) and net profit of ₹1.4 Cr (+100.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.4 Cr · +100.0% YoY
Bal Pharma Board Meeting Date
Bal Pharma Limited informs exchanges of a board meeting on November 11, 2026, to consider unaudited standalone and consolidated results for Q2 FY2026-27. This is a prior intimation with no results figures attached yet.
Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern as mandated under Regulation 31(1)(b) of the SEBI Listing Regulations.
Bal Pharma Dividend
Bal Pharma disbursed its FY25-26 final dividend of ₹1.20 per share on October 9, 2026. Dividends for shareholders with incomplete KYC or bank details have been withheld.
Bal Pharma Management Change
Bal Pharma Limited announced a change in designations for directors Ravindra Kumar Kothari and Virupakshaya Himesh, effective October 1, 2026.
Other legal & regulatory announcements
All →iSERA Lifesciences Legal & Regulatory
iSERA Lifesciences disclosed a SEBI warning letter for non-filing of Reg 7(3), 13(3) and 47. No financial or operational impact is stated.
The Grob Tea Company Legal & Regulatory
Grob Tea discloses a pending arbitration and NCLT case against Larica LED Products for Rs. 2.26 Crore recovery. The dispute arose under a consortium agreement for onward supply to PSUs.
- Value
- ₹2.26 Cr
Sapphire Foods India Legal & Regulatory
Sapphire Foods received a rectified GST order confirming a ₹4.39 Cr tax demand from Karnataka. The demand increased from the earlier ₹3.07 Cr figure.
- Value
- ₹4.39 Cr
B L Kashyap & Sons Legal & Regulatory
Board noted NSE's ₹48,000 fine for delayed Q2 shareholding pattern filing under Regulation 31. Company paid the fine and directed stronger compliance controls.
- Value
- ₹0.00 Cr
Sterling and Wilson Renewable Energy Legal & Regulatory
SWSOLAR's ICC arbitration with TSGF SPA extended until March 31, 2027. A conditional settlement was executed with no financial impact until implementation.
Committed Cargo Care Legal & Regulatory
Supreme Court upheld NCLT order directing CCCL's directors to personally pay ₹2 Crore to Stockflow's estate. No liability attaches to the Company itself.
- Value
- ₹2.00 Cr